Mindpeak secures $15.3M in series A funding to accelerate growth in AI-based digital pathology
recent articles
Indica Labs announces new webinar. Deploying the Slide QC 2.0 network in HALO AI and HALO AP® Date: 27 October 2022 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 CEST Location: Webinar REGISTER NOW Learn about the...
Indica Labs Invites You To Attend Their 2022 Pathology Visions Pre-conference Workshop Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration Date: 16 October...
Mindpeak: Mindpeak’s PD-L1 Lung AI achieves 92% concordance in clinical DRT test without human intervention. Mindpeak's AI software for scoring PD-L1 in non-small cell lung cancer (NSCLC) has passed the Digital Readout Test (DRT) of German...
Another manufacturer has FDA clearance for primary diagnosis for clinical use. Be sure to check out the NanoZoomer S260MD slide scanner for primary diagnostics. Hamamatsu Photonics K.K., a global leader in imaging technology, today...
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) — Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular matching and prediction analysis, announced...
VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / September 27, 2022 /Â Xybion Digital Inc. (TSXV:XYBN) ("Xybion" or the "Company"), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life...
